asking for more data before the agency considers approving an experimental inhaled cystic fibrosis drug.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,207 news
and
1,328 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
News
Recent news on this topic.
Shares of biotechnology company Amylin Pharmaceuticals Inc. jumped Monday following billionaire investor Carl Icahn's...
(tie goes to the issue with the largest market value). Subindustry Company Ticker S&P STARS Rank Price (8/22/08)...
Federal regulators on Friday approved a biotech drug from Amgen Inc. to treat a rare blood-clotting disorder.
Biotechnology giant Genentech Inc. rejected a $43.7 billion buyout offer from its majority owner Roche on Wednesday but...
generic competition for ViroPharma's only marketed treatment, Vancocin, which treats gastrointestinal tract infections.
Extract not available.
Top Sources: Business of Biotechnology
- investorideas.com
- bloomberg.com
- youtube.com
- contrarianprofits.com
- industry.bnet.com
- Forbes.com
- SeekingAlpha.com
- bioedgeconsulting.com
- thestreet.com
- pharma-iq.com
account